Abiopharma

Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements

New Form 4 - Gevo, Inc. Filed: 2025-08-04 AccNo: 0001415889-25-020960 Size: 6 KB

New Form 6-K - Cellectis S.A. Filed: 2025-08-04 AccNo: 0001171843-25-004999 Size: 123 KB

New Form 8-K - HEALTHSTREAM INC Filed: 2025-08-04 AccNo: 0001437749-25-024629 Size: 463 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 15-12G - Elevation Oncology, Inc. Filed: 2025-08-04 AccNo: 0001140361-25-028624 Size: 13 KB

New Form 4 - Cencora, Inc. Filed: 2025-08-04 AccNo: 0001685596-25-000004 Size: 4 KB

New Form 8-K - RxSight, Inc. Filed: 2025-08-04 AccNo: 0000950170-25-102065 Size: 192 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 8-K - WINDTREE THERAPEUTICS INC /DE/ Filed: 2025-08-04 AccNo: 0001437749-25-024625 Size: 155 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Phreesia, Inc. Filed: 2025-08-04 AccNo: 0001127602-25-019963 Size: 5 KB

New Form 8-K - CATALYST PHARMACEUTICALS, INC. Filed: 2025-08-04 AccNo: 0001193125-25-172653 Size: 157 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form SCHEDULE 13G - ImageneBio, Inc. Filed: 2025-08-04 AccNo: 0001172661-25-002868 Size: 11 KB

New Form 4 - Pacira BioSciences, Inc. Filed: 2025-08-04 AccNo: 0001396814-25-000095 Size: 5 KB